Jazz Pharmaceuticals, Inc. (JAZZ) Financials
Key financial figures for Jazz Pharmaceuticals, Inc. (Q2 2026).
Jazz Pharmaceuticals plc reported revenue of $1.21 billion for Q2 FY2026, up 15.5% from the same period a year earlier. Net income was $192.8 million, or $2.78 per share. Operating margin came to 20.54%, against -65.64% a year earlier. Free cash flow for the period was $397.6 million. Across the last 5 reported quarters, quarterly revenue has risen from $1.05 billion in Q2 FY2025 to $1.21 billion in Q2 FY2026. The figures above are as filed, and the full income statement, balance sheet and cash flow history for Jazz Pharmaceuticals plc are on the SentiSense financials page.
- Revenue
- $1.2B
- Net Income
- $193M
- EPS
- $3.05
- Total Assets
- $11.1B
- Operating Cash Flow
- $416M
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q2 FY2026 | $1.2B | $193M | $2.78 | 20.54% | $398M |
| Q1 FY2026 | $1.1B | $293M | $4.43 | 20% | $389M |
| Q4 FY2025 | $1.2B | $203M | $3.34 | 75.9% | $297M |
| Q3 FY2025 | $1.1B | $251M | $4.08 | 5.11% | $459M |
| Q2 FY2025 | $1.0B | -$718M | -$11.74 | -65.64% |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | $4.3B | -$356M | -$5.84 | 5.26% | $1.1B |
| FY2024 | $4.1B | $560M | $8.65 | 17.61% | $1.3B |
| FY2023 | $3.8B | $415M | $6.10 | 15.09% | $1.1B |
Frequently asked questions
What was Jazz Pharmaceuticals plc's revenue last quarter?
Jazz Pharmaceuticals plc reported revenue of $1.21 billion for Q2 FY2026, up 15.5% from the same period a year earlier.
Is Jazz Pharmaceuticals plc profitable?
Yes. Jazz Pharmaceuticals plc reported net income of $192.8 million for Q2 FY2026, a net margin of 15.96% on revenue.
How has Jazz Pharmaceuticals plc's margin trended?
Operating margin was 20.54% in Q2 FY2026, compared with -65.64% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.
How much free cash flow did Jazz Pharmaceuticals plc generate?
Jazz Pharmaceuticals plc generated free cash flow of $397.6 million in Q2 FY2026, after capital expenditure.
Full income statement, balance sheet and cash flow for Jazz Pharmaceuticals, Inc. on SentiSense, with up to forty quarters and twenty fiscal years of history.